Stock News and Filings Feed


Add RMD
to your dashboard

3 Dividend Healthcare Stocks

2017-08-16 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Earnings Review and Free Research Report: ResMed Adjusted Diluted EPS Increased 4%

2017-08-16 accesswire
LONDON, UK / ACCESSWIRE / August 16, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on ResMed Inc. (NYSE: RMD), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=RMD, following the Company's reporting of its financial results on August 01, 2017, for the fourth quarter fiscal 2017. The Company's revenue increased 7.3% on a y-o-y basis. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:

Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for its Brachytherapy Applicators

2017-08-11 accesswire
LONDON, UK / ACCESSWIRE / August 11, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Varian Medical Systems, Inc. (NYSE: VAR), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=VAR. The Company announced on August 09, 2017, that it has signed an agreement with Bionix® Radiation Therapy to become the non-exclusive distributor of Bionix®'s brachytherapy applicators.

HealthSouth Invades Big Pharma Duet To Place Atop 'Safer' Dividend Healthcare Pack For Gains In August

2017-08-11 seekingalpha
Top "safer" dividend Healthcare dog GSK's 20% net gain was nearly half the combined estimated amounts for OMI, per analyst targets 8/4/17.

Worldwide Sleep Apnea Device Market 2017-2023 - Technological Advances in Diagnostics and Therapeutic Devices

2017-08-10 prnewswire
The "Worldwide Sleep Apnea Device Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering.

ResMed: Buy On The Dip

2017-08-04 seekingalpha
ResMed the sleep device and software pioneer reports notably successful Q4 earnings and on that the stock price slipped 9%--Huh? It's a good time to buy.

ResMed Tops Expectations but Falls Anyway

2017-08-03 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

ResMed Announces Results For The Fourth Quarter Of Fiscal Year 2017

2017-08-02 devicespace
SAN DIEGO, Aug. 1, 2017 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended June 30, 2017. Revenue for the quarter was $556.7 million, a 7 percent increase compared to the same period of the prior year. Excluding the contribution from the Brightree business acquired in April 2016, revenue for the quarter was $520.5 million, a 6 percent increase.   

ResMed (RMD) Q4 Earnings Top, 2020 Strategic Goals on Track

2017-08-02 zacks
ResMed Inc. (RMD - Free Report) announced fourth-quarter fiscal 2017 adjusted earnings per share (EPS) of 77 cents, up 4.1% from the prior-year quarter level. Earnings also beat the Zacks Consensus Estimate by 2 cents.

ResMed (RMD) Q4 2017 Results - Earnings Call Transcript

2017-08-02 seekingalpha
Welcome to the Q4 Fiscal Year 2017 ResMed, Inc. Earnings Conference Call. My name is Mariama, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. Please note that this conference is being recorded.

Medical Products Earnings Due on Aug 1: IDXX, RMD

2017-07-31 zacks
We are at the second half of the second-quarter earnings season and per our Earnings Preview, till Jul 28, around 286 S&P 500 members (68.8% of the Index’s total market cap) have reported their quarterly numbers.

Respiratory Devices Market Worth US$22.1 Billion by 2025: Increasing Prevalence of COPD Propels Growth

2017-07-31 prnewswire
Transparency Market Research (TMR) in one of its recent reports observes the global respiratory devices market to be fragmented with the presence of several small and medium-size companies that operate in niche market segments. In order to sustain the competition, leading players are striving to leverage new technologies to upgrade their existing products as well as to expand their product portfolios.

Is a Surprise in Store for ResMed (RMD) in Q4 Earnings?

2017-07-21 zacks
ResMed Inc. (RMD - Free Report) is slated to report fourth-quarter fiscal 2017 results, after markets close on Aug 1.

Here's Why You Should Add ResMed to Your Portfolio Now

2017-07-12 zacks
California-based ResMed, Inc. (RMD - Free Report) has been on a healthy growth trajectory of late. The company is a leading global manufacturer and distributor of generators, masks and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders.

ResMed Sees Potential in SDB Market, Eyes Global Growth

2017-07-07 zacks
On Jul 6, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD - Free Report) . The company is a global manufacturer and distributor of generators, masks and related accessories for treatment of sleep-disordered breathing (SDB) and other respiratory disorders. At present, the company’s line of products includes airflow generators, diagnostic products, mask systems, headgear and other accessories.

Global Respiratory Care Devices Market 2017-2023 - Therapeutics, Monitoring, Diagnostics, and Consumables

2017-06-29 prnewswire
Research and Markets has announced the addition of the "Global Respiratory Care Devices Market - Drivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering.

ResMed (RMD) at 52-Week High: What's Driving the Stock?

2017-06-20 zacks
Share price of ResMed Inc. (RMD - Free Report) scaled a new 52-week high of $79.22 on Jun 19, eventually closing a bit lower at $78.91. The company has gained 28.1% over the past six months, ahead of the S&P 500’s 7.6% gain. The stock has a market cap of $11.19 billion.

Project $1M: Outperformance Continues, But I'm Still Concerned

2017-06-05 seekingalpha
While I've been pleased with the progress of the portfolio, I'm not sure how much longer the outperformance can continue.

Why Is ResMed (RMD) Down 3.8% Since the Last Earnings Report?

2017-05-31 zacks
It has been about a month since the last earnings report for ResMed Inc. (RMD - Free Report) . Shares have lost about 3.8% in that time frame, underperforming the market.

Global Respiratory Care Device Market Growth Opportunities 2017-2022 - Research and Markets

2017-05-25 prnewswire
Research and Markets has announced the addition of the "Growth Opportunities in the Global Respiratory Care Device Market" report to their offering.

1
share
BRIEF-Coherus Biosciences prevails in '135 IPR decision

2017-05-17 reuters
* Coherus Biosciences - patent trial, appeal board of U.S. Patent And Trademark Office ruled in favor of review of Abbvie's U.S. patent 8,889,135

U.S. finds Japanese, Turkish rebar exports dumped

2017-05-17 reuters
WASHINGTON May 16 U.S. Commerce Department Secretary Wilbur Ross said on Tuesday the department had made a final finding of dumping of steel concrete reinforcing bar (rebar) exports from Japan and Turkey, and subsidization by Turkey.

2
shares
PRESS DIGEST- British Business - May 17

2017-05-17 reuters
May 17 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

6
shares
ResMed withdraws U.S. trade complaint against Fisher & Paykel Healthcare

2017-05-17 reuters
WELLINGTON Health appliance firm ResMed Inc has dropped a complaint against New Zealand's Fisher & Paykel Healthcare at the U.S. International Trade Commission (USITC), Fisher & Paykel said on Wednesday.

3
shares
BRIEF-Alvopetro qtrly loss per share $0.01

2017-05-17 reuters
* Q1 average daily production decreased to 39 bopd, a 26% reduction from Q4 of 2016

Fintel IR - Find the Right Investors for Your Company, Instantly!

Fintel IR combines the comprehensive Fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy. Learn more now!